Leverage Shares 2X Long FIX Daily ETF (BATS:FIXX) CEO Sells $26,798.72 in Stock

Leverage Shares 2X Long FIX Daily ETF (BATS:FIXX) CEO Jodie Pope Morrison sold 3,221 shares of the company’s stock in a transaction on Tuesday, October 6th. The shares were sold at an average price of $8.32, for a total value of $26,798.72. Following the completion of the transaction, the chief executive officer directly owned 340,038 shares in the company, valued at approximately $2,829,116.16. This represents a 0.94% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Jodie Pope Morrison also recently made the following trade(s):

• On Tuesday, August 25th, Jodie Pope Morrison sold 9,845 shares of Leverage Shares 2X Long FIX Daily ETF stock. The stock was sold at an average price of $16.56, for a total value of $163,033.20.

Leverage Shares 2X Long FIX Daily ETF Price Performance

Shares of FIXX traded down $0.73 during midday trading on Friday, reaching $9.56. 254 shares of the stock were exchanged, compared to its average volume of 2,977. Leverage Shares 2X Long FIX Daily ETF has a twelve month low of $9.14 and a twelve month high of $15.92.

Homology Medicines, Inc was a clinical-stage biotechnology company focused on developing genetic medicines for patients with rare diseases. The company sought to use its proprietary human-derived adeno-associated virus vectors, known as AAVHSCs, to deliver gene therapies in vivo and address the underlying causes of inherited disorders.

Its development programs included HMI-103, an investigational gene therapy for phenylketonuria, as well as earlier programs targeting other rare diseases.